Florencia Halperin, an endocrinologist and chief medical officer at the Boston weight loss clinic Form Health and spokesperson for The Obesity Society, a national professional organization focused on weight loss
Who Should Consider L-Carnitine
Expected results: Energy improvements within 1-2 weeks
Conclusion In conclusion, our study findings suggest that the use of GLP-1RAs may offer significant benefits for patients who have undergone bariatric surgery and are facing WR or IWL Additionally, it is important to highlight that the safety profile of these medications was favorable, with no significant adverse events reported
The question has shifted from "is it too expensive to cover GLP-1?" to "is it too expensive not to?" As clinical data accumulates showing that GLP-1 medications reduce the incidence and severity of the most expensive chronic diseases, payers are recognizing that proactive treatment of obesity saves money compared to treating its downstream consequences
notably, those changes correlated with higher peripheral inflammation (plasma cytokines) [127, 128]